Core I - More than 90 percent of the global HIV burden falls outside of the United States: 70 percent in Sub-Saharan Africa, 14 percent in Asia and the Pacific, 5 percent in Latin America and the Caribbean, and 4 percent in Eastern Europe and Central Asia. The majority of these regions comprise low- and middle-income countries (LMIC), which lack both scientific and clinical resources to treat existing HIV infections and prevent new ones. Mozambique, for example, has 0.055 doctors per 1000 persons; Zimbabwe, 0.074; India, 0.725; and Brazil, 1.852. The International Core (IC) of the San Diego (SD) CFAR addresses these discrepancies by serving as a resource hub for foreign research supported by our Center. Our local investigators guide foreign scientists in writing pilot grant proposals, designing studies, and analyzing data. Our Co-Directors and administrative team explain NIH regulatory and funding requirements. We provide similar assistance as well as valuable foreign connections for local SD CFAR researchers who wish to pursue international HIV research. Thus we encourage emerging investigators to gain independence and pursue their own funding. Simultaneously, we add value to the SD CFAR by fostering long-term collaborations between local and foreign investigators, which leads to subsequent peer-reviewed publications and grant funding. We also refer our local and international investigators to other Cores for specialized services that will benefit their SD CFAR-funded projects. International projects often take longer than domestic studies to generate a return on investment, so we emphasize productivity since the Core was initiated. From 2007 to date, we have supported a total of 63 studies that have resulted in 81 papers and $42.7 million in subsequent funding (ROI $25). Over the next 5 years, the IC will expand and improve its services through the following 4 units, each having specific responsibilities in service to the SD CFAR and the international HIV research community: Evaluation Unit?To ensure applications for International Pilot grants contribute to the high-impact science associated with the SD CFAR; Regulatory Unit?Ensure research projects recommended by the Evaluation Unit and the Developmental Core Grant Review Committee meet NIH and local regulatory standards; Communications Unit?Expedite application and review processes, and apply, clarify, or update policies; Training and Mentoring Unit?Implement administrative and technical training for foreign investigators and ensure that domestic and international investigators receive in-depth mentoring as needed from senior SD CFAR members and International Core Co-Directors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-26
Application #
9906066
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
26
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :
Stone, Jack; Fraser, Hannah; Lim, Aaron G et al. (2018) Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis. Lancet Infect Dis 18:1397-1409
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Prakash, Katya; Gianella, Sara; Dubé, Karine et al. (2018) Willingness to participate in HIV research at the end of life (EOL). PLoS One 13:e0199670
Fraser, Hannah; Mukandavire, Christinah; Martin, Natasha K et al. (2018) Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Addiction 113:2118-2131
Macal, Monica; Jo, Yeara; Dallari, Simone et al. (2018) Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity 48:730-744.e5
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :

Showing the most recent 10 out of 921 publications